RCM
EIGR
RA Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,415,458
| Closed | -$33.8M | – | 32 |
|
|
2019
Q1 | $33.8M | Hold |
2,415,458
| – | – | 1.46% | 20 |
|
|
2018
Q4 | $24.5M | Buy |
+2,415,458
| New | +$24.5M | 1.43% | 20 |
|
|
2017
Q2 | – | Sell |
-354,200
| Closed | -$4.06M | – | 26 |
|
|
2017
Q1 | $4.06M | Hold |
354,200
| – | – | 0.5% | 23 |
|
|
2016
Q4 | $4.13M | Hold |
354,200
| – | – | 0.58% | 22 |
|
|
2016
Q3 | $4.74M | Buy |
354,200
+62,500
| +21% | +$837K | 0.49% | 26 |
|
|
2016
Q2 | $5.78M | Hold |
291,700
| – | – | 0.8% | 24 |
|
|
2016
Q1 | $4.89M | Buy |
+291,700
| New | +$4.89M | 0.63% | 32 |
|
|
2015
Q2 | – | Sell |
-40,900
| Closed | -$775K | – | 66 |
|
|
2015
Q1 | $775K | Hold |
40,900
| – | – | 0.08% | 54 |
|
|
2014
Q4 | $799K | Buy |
+40,900
| New | +$799K | 0.09% | 46 |
|